Table 2 Type of intervention, operative and post-operative details
Overall N = 300 | |
|---|---|
Type of cardiac intervention | |
CABG, n (%) | 214 (71.3) |
CABG + AVR, n (%) | 57 (19.0) |
CABG + AVR + MVR, n (%) | 4 (1.3) |
CABG + AVR + tricuspid valve repair, n (%) | 1 (0.3) |
CABG + MVR, n (%) | 11 (3.7) |
CABG + MVR + tricuspid valve repair, n (%) | 1 (0.3) |
CABG + Bentall, n (%) | 4 (1.3) |
CABG + Bentall + mitral valve repair, n (%) | 1 (0.3) |
CABG + Bentall + tricuspid valve repair, n (%) | 1 (0.3) |
CABG + ventricular aneurysmectomy, n (%) | 1 (0.3) |
CABG + AVR + ascending aorta and aortic arch replacement, n (%) | 1 (0.3) |
CABG + AVR + ascending aorta replacement, n (%) | 1 (0.3) |
CABG + MVR + AVR + ascending aorta remodeling/replacement, n (%) | 3 (1.0) |
Operative details | |
CABG off-pump, n (%) | 7/214 (3.3) |
Number of distal anastomoses | |
1, n (%) 2, n (%) 3, n (%) 4, n (%) 5, n (%) 6, n (%) | 67 (22.3) 125 (41.7) 74 (24.7) 28 (9.3) 5 (1.7) 1 (0.3) |
Left internal mammary artery graft, n (%) | 270 (90) |
Right internal mammary artery graft, n (%) | 10 (3.3) |
Saphenous vein graft, n (%) | 249 (83) |
Number of surgical procedures | |
Isolated CABG, n (%) 2 procedures, n (%) 3 procedures, n (%) | 209 (69.7) 79 (26.3) 12 (4.0) |
Cardiopulmonary bypass time, minutes, median [Q1-Q3] | 106 [78–133] |
Aortic cross clamp time, minutes, median [Q1-Q3] | 65 [47–99] |
Post-operative details | |
Post-operative creatinine, mg/dl, median [Q1-Q3] | 0.99 [0.82–1.23] |
Post-operative hs-cTn I, ng/L, median [Q1-Q3] (patients) | |
0 h 3–6 h 9–12 h 15–18 h 21–24 h 33–36 h 39–48 h | 1353 [674–2469] (299) 2299 [1383–4242] (289) 2481 [1529–5409] (280) 2109 [1094–5156] (251) 1592 [814–3945] (257) 1057 [561–2940] (248) 1064 [458–3328] (162) |
ECG criteria (new Q wave), n (%) | 6 (2.0) |
Echocardiographic criteria (new regional wall motion abnormalities), n (%) | 19/299* (6.4) |
Post-operative evidence of thrombotic occlusion of the graft and/or native coronary artery, n (%) | 3 (1.0) |
PMI, n (%) | 24 (8.0) |
Post-operative LVEF, %, median [Q1-Q3], (patients) | 60 [50–64] (299) |
Post-operative LVEF decrease ≥ 10%, n (%) | 32/299* (10.7) |
In-hospital composite morbidity after surgery | |
Stroke, n (%) | 3 (1.0) |
Need for renal replacement therapy, n (%) | 9 (3) |
IABP/ECMO support, n (%) | 6 (2.0) |
Reintervention, n (%) | 7 (2.3) |
In hospital all-cause death, n (%) | 5 (1.7) |
Time from intervention to discharge/transfer, days, median [Q1–Q3] | 9 [7–13] |